The protease medicines company

Our programs:

Latest news

Aug 05, 2021

Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update

Jul 22, 2021

Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies

Jul 19, 2021

Catalyst Biosciences Presents Four Posters at the International Society for Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress

X